RESUMO
OBJECTIVE: Obesity is a growing epidemic in the United States. While many adverse effects of obesity on surgical outcome are well studied, a direct correlation among obesity, pseudarthrosis, and adjacent segment pathology is not well defined. In this study we aimed to identify the effect of body mass index (BMI) on pseudarthrosis, adjacent segment pathology (ASP), and reoperation after short-segment (1-3 levels) open posterior lumbar fusion (PLF). METHODS: This is a retrospective study of patients with degenerative spine pathologies who underwent 1-, 2-, or 3-level PLF surgery between 2010 and 2020. The relevant medical and imaging records were reviewed, and the following variables were recorded: age, gender, BMI, smoking status, surgical details, follow-up length, need for reoperation, indication for reoperation (pseudarthrosis or occurrence of ASP). RESULTS: We included363 patients in our study. Twenty-five patients (6.9%) developed pseudarthrosis, 109 (30%) developed ASP, and 104 patients (28.7%) underwent reoperation for either of these reasons. BMI was significantly less in those who developed pseudarthrosis compared with those who did not (28.6 ± 5.5 vs. 31.2 ± 6.2, respectively; P = 0.04). BMI was not significantly different in those who developed ASP or underwent reoperation compared with those who did not (P = 0.06 and 0.08, respectively). Multivariate regression analysis showed none of the variables in the model (age, gender, tobacco use, BMI, and its classes) significantly predicted pseudarthrosis, ASP, or reoperation (P > 0.1 for all variables). CONCLUSIONS: Obese patients undergoing short-segment open PLF have comparable results in terms of pseudarthrosis, ASP, and reoperation.
RESUMO
INTRODUCTION: Interbody devices (IBDs) have been shown to improve outcomes when used in posterior lumbar fusion (PLF) surgery; however,the exact extent of their clinical benefit remains a current topic of interest. Our primary objective in this study was to identify whether the use of an IBD at every level of fusion construct would affect fusion outcomes such as adjacent segment pathology (ASP) and pseudarthrosis after one- to three-level PLF surgery. METHODS: This was a single-institution retrospective study. We studied the association of factors such as smoking status, BMI, gender, age, and number of IBDs on the development of ASP and pseudarthrosis. To study the effect of independent variables on ASP and pseudoarthrosis, univariate and multivariate regression analyses were used. RESULTS: The study included 2,061 patients with a history of posterior lumbar fusion who were identified and reviewed. Among these, 363 patients met our inclusion criteria; 247 patients had a minimum follow-up of six months and were finally included in the study. The median follow-up was 30 months. Among the 247 patients, 105 (42.5%) and 24 (9.7%) experienced ASP and pseudarthrosis, respectively. Gender and use of IBD significantly affected the presence of pseudarthrosis (with a higher rate in males and those without any IBDs). Gender, age, BMI, and use of IBDs did not affect ASP. Moreover, using an IBD at each fused level reduced the pseudarthrosis rate significantly compared to when IBDs were not used at all levels (7.3% vs. 27.6%, p <0.001), while there was no significant difference in the rate of ASP (43.6% vs. 34.5%, p = 0.35). CONCLUSIONS: In patients undergoing one- to three-level PLF surgery, the use of an IBD at all levels of the fusion construct significantly reduces the rate of pseudarthrosis. There was no significant correlation between the rates of ASP. Studies with a larger sample size and a longer follow-up time are suggested to validate our results for pseudoarthrosis and ASP. Our results suggest the use of an IBD per fusion level in short-segment PLF surgeries.